Search results
Mankind Pharma Share Price: Find the latest news on Mankind Pharma Stock Price. Get all the information on Mankind Pharma with historic price charts for NSE / BSE.
Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.
Price of SBI on previous budgets. Get Mankind Pharma latest Key Financial Ratios, Financial Statements and Mankind Pharma detailed profit and loss accounts.
Mankind Pharma Ltd. Share Price Today: CLOSE 2129.7, HIGH 2163.25, LOW: 2124.8. Get latest balance sheet, annual reports, quarterly results, and price chart.
4 days ago · Mankind Pharma share price was Rs 2,129.10 as on 02 Jul, 2024, 03:59 PM IST. Mankind Pharma share price was down by 1.47% based on previous share price of Rs 2,129.2. Mankind Pharma share price trend: Last 1 Month: Mankind Pharma share price moved down by 0.50%; Last 3 Months: Mankind Pharma share price moved down by 11.04%
5 days ago · Mankind Pharma Limited Stock Price Today, Live NSE Share Price: Get the latest Mankind Pharma Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Get the latest Mankind Pharma Ltd (MANKIND) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Apr 24, 2023 · Mankind Pharma, India’s fourth largest pharmaceutical company in terms of domestic sales and second largest in terms of sales volume for the financial year 2022, will float its first public...
4 days ago · Get Mankind Pharma Ltd. share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding, and financial report.
Get the latest Mankind Pharma Ltd (543904) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
